We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
+18.15%
1 Year Est. Return
+77.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
+$4.84M
Cap. Flow
-$3.33M
Cap. Flow %
-2.77%
Top 10 Hldgs %
38.28%
Holding
176
New
49
Increased
27
Reduced
29
Closed
53

Top Sells

Rank Stock Value
1
WOW
WideOpenWest
WOW
+$4.89M
2
DK icon
Delek US
DK
+$3.71M
3
ARVN icon
Arvinas
ARVN
+$3.27M
4
KROS icon
Keros Therapeutics
KROS
+$2.84M
5
SGRY icon
Surgery Partners
SGRY
+$2.68M

Sector Composition

Rank Sector Weight
1 Healthcare 32.77%
2 Real Estate 10.33%
3 Consumer Discretionary 9.43%
4 Communication Services 9.34%
5 Technology 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMA
101
ImageneBio Inc
IMA
$63.2M
$126K 0.1%
18,244
+3,244
+22% +$24.1K
CPAC
102
Cementos Pacasmayo
CPAC
$1.03B
$125K 0.1%
+12,000
New +$91.9K
SPKL
103
Spark I Acquisition Corp
SPKL
$101M
$124K 0.1%
10,813
-3,360
-24% -$38.2K
TASK icon
104
TaskUs
TASK
$531M
$118K 0.1%
+10,000
New +$128K
PMTR
105
Perimeter Acquisition Corp I
PMTR
$320M
$103K 0.09%
+10,000
New +$103K
MCGAU
106
Yorkville Acquisition Corp Unit
MCGAU
$157M
$103K 0.09%
10,000
RAAQ
107
DELISTED
Real Asset Acquisition Corp
RAAQ
$102K 0.08%
+10,000
New +$103K
SITC icon
108
SITE Centers
SITC
$232M
$89.9K 0.07%
14,000
SHCO
109
DELISTED
Soho House & Co
SHCO
$89.6K 0.07%
10,000
-83,200
-89% -$738K
ANTX icon
110
AN2 Therapeutics
ANTX
$178M
$74.1K 0.06%
65,000
NKTX icon
111
Nkarta
NKTX
$162M
$59.3K 0.05%
+32,078
New +$64.1K
BRNS
112
Barinthus Biotherapeutics
BRNS
$24.6M
$59.1K 0.05%
+84,441
New +$84.3K
VYNE icon
113
VYNE Therapeutics
VYNE
$19.1M
$58K 0.05%
2,000
+1,000
+100% +$20.1K
PMVP icon
114
PMV Pharmaceuticals
PMVP
$62.9M
$56.9K 0.05%
45,500
ANEB
115
DELISTED
Anebulo Pharmaceuticals
ANEB
$50.5K 0.04%
50,000
+30,000
+150% +$68.5K
MGNX icon
116
MacroGenics
MGNX
$254M
$48.7K 0.04%
30,220
SEER icon
117
Seer Inc
SEER
$108M
$36.6K 0.03%
20,000
AIFC
118
AI Financial Corp
AIFC
$55.6M
$31.9K 0.03%
29,000
-19,300
-40% -$37.2K
RLYB icon
119
Rallybio
RLYB
$86.6M
$27.4K 0.02%
5,000
-5,376
-52% -$27.7K
EMISR
120
Emmis Acquisition Corp Rights
EMISR
$18.1K 0.02%
+18,107
New +$2.88K
NVRI icon
121
CALL
Enviri
NVRI
$620M
$17.9K 0.01%
+1,000
New +$14.9K
MLACR
122
DELISTED
Mountain Lake Acquisition Corp Right
MLACR
$15.6K 0.01%
+15,000
New +$5.88K
PLYM
123
PUT
DELISTED
Plymouth Industrial REIT
PLYM
$2.19K ﹤0.01%
+100
New +$2.2K
AIV
124
Aimco
AIV
$377M
-15,000
Closed -$119K
AMPY icon
125
Amplify Energy
AMPY
$155M
-10,000
Closed -$52.5K

Similar funds

Rangeley Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Rangeley Capital held 176 positions worth $120M, up 4.2% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rangeley Capital's Q4 2025 filing shows 49 new, 27 increased, 29 reduced and 53 closed positions. Its largest new stake was Golden Entertainment: 209,881 shares worth $5.71M. The largest sale was WideOpenWest, an estimated $4.89M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Real Estate and Consumer Discretionary.

  • Rangeley Capital's largest Q4 2025 buy was Golden Entertainment: 209,881 shares worth $5.71M.
  • Rangeley Capital added most to Repare Therapeutics in Q4 2025, an estimated $1.29M increase.
  • Rangeley Capital's biggest Q4 2025 reduction was Delek US, cutting an estimated $3.71M.
  • Rangeley Capital fully exited WideOpenWest in Q4 2025, selling an estimated $4.89M.
  • Rangeley Capital's ten largest holdings make up 38% of its $120M portfolio in Q4 2025.
  • Rangeley Capital opened 49 new positions and closed 53 in Q4 2025.
  • Rangeley Capital's portfolio value rose 4.2% quarter-over-quarter to $120M.

Based on Rangeley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.